<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html>
<head>
<title>Patent US6840954 - Systems and methods using vasoconstriction for improved thermal treatment of ... - Google Patents</title>
<script>(function(){var a=function(e){this.t={};this.tick=function(e,i,d){d=void 0!=d?d:(new Date).getTime();this.t[e]=[d,i]};this.tick("start",null,e)},b=new a;window.jstiming={Timer:a,load:b};if(window.performance&&window.performance.timing){var c=window.performance.timing,f=window.jstiming.load,g=c.navigationStart,h=c.responseStart;0<g&&h>=g&&(f.tick("_wtsrt",void 0,g),f.tick("wtsrt_","_wtsrt",h),f.tick("tbsd_","wtsrt_"))}
try{var j=null;window.chrome&&window.chrome.csi&&(j=Math.floor(window.chrome.csi().pageT),f&&0<g&&(f.tick("_tbnd",void 0,window.chrome.csi().startE),f.tick("tbnd_","_tbnd",g)));null==j&&window.gtbExternal&&(j=window.gtbExternal.pageT());null==j&&window.external&&(j=window.external.pageT,f&&0<g&&(f.tick("_tbnd",void 0,window.external.startE),f.tick("tbnd_","_tbnd",g)));j&&(window.jstiming.pt=j)}catch(k){};})();
</script><link rel="stylesheet" href="/patents/css/_173f3eb08751494e5351928575aaa593/kl_patents_bundle.css" type="text/css">
<script type="text/javascript" src="/books/atb_173f3eb08751494e5351928575aaa593.js"></script><script type="text/javascript">_OC_addMsgs({21697:"View sample", 20198:"Web", 22224:"Sample eBook", 19688:"%1$s More", 18955:"Private bookshelf", 18138:"Back Cover", 21936:"eReader", 22144:"Added to {$count} shelves", 22084:"Good for:", 18871:"Less", 18802:"PDF", 18870:"More", 22087:"Read the first chapter - FREE!", 21825:"Tablet / iPad", 22233:"You have not made this book available for reading offline.", 21808:"Help with devices \x26 formats", 22192:"This book is not available offline.", 18764:"Purchased", 21713:"Delete forever", 26364:"Flowing text", 18464:"Add to my library", 21833:"This eBook, like all Google eBooks, is formatted to be readable on tablet devices like Android tablets and the iPad.", 19696:"Discuss this patent on Stack Exchange", 18295:"Download", 22103:"Cancelled - price change", 18278:"Limited preview", 19097:"Some pages are omitted from this book preview.", 22254:"Buy and read instantly wherever you go with books on Google Play", 18519:"Embed", 22105:"Cancelled - publisher cancellation", 18279:"Snippet view", 18497:"Write review", 22036:"Pre-ordered", 18898:"EPUB", 18277:"Full view", 19697:"Discuss this application on Stack Exchange", 18632:"Paste link in \x3cb\x3eemail\x3c/b\x3e or \x3cb\x3eIM\x3c/b\x3e", 21832:"This eBook, like all Google eBooks, is formatted to be readable on the web.", 21919:"Make available offline", 22011:"Pre-order eBook - %1$s", 22143:"Added to {$shelf}", 22001:"eBook - FREE", 18163:"Page %1$s", 22223:"Sample print book", 22170:"The format of this book is currently unknown. We will update this when we receive the information from the publisher.", 26365:"Pages %1$s to %2$s are not shown in this preview.", 22226:"Read the book for FREE", 21846:"This eBook does not include scanned pages, which retain the format of a printed book. Instead, the text can be  adjusted and it flows to fit any screen.", 22161:"Help with pre-orders", 22160:"Available on: %1$s", 18299:"%1$d pages", 22002:"eBook - %1$s", 19690:"Find prior art", 18242:"Loading...", 18140:"Contents", 22000:"preview it", 21841:"This eBook may be hard to read on smartphones like Android and iPhone / iPod touch.", 21843:"This eBook includes flowing text, so you can adjust the font size and style to read comfortably on any device.", 19144:"No preview", 21861:"Scroll right", 21837:"This eBook is good for smartphones like Android and iPhone / iPod touch.", 18768:"Selection text", 22249:"Learn more about books on Google Play", 22080:"Cancelled", 18516:"Share this clip", 18287:"more \x26raquo;", 22089:"read eReader instructions", 18523:"Image", 21663:"Scanned pages", 26380:"Page %1$s is not part of this book preview.", 18385:"Download PDF", 22104:"Cancelled - problem with eBook", 21840:"This Google eBook does not include flowing text, so you cannot adjust the font on an eReader.", 18137:"Front Cover", 21909:"This book is not available for reading offline.", 18244:"Learn more", 18631:"This is a preview. The total pages displayed will be limited.", 18042:"Buy this book", 18108:"You have either reached a page that is unavailable for viewing or reached your viewing limit for this book.", 18130:"Page", 18005:"Search in this patent", 22085:"Features:", 22234:"This book has not completely downloaded for reading offline.", 22221:"There was an error downloading this volume.", 19713:"View PDF", 18370:"%1$d reviews", 21844:"This book does not include flowing text, so you cannot adjust the font. Instead, you see images of pages, with a fixed layout. This is good for larger screens,  but not always ideal for eReaders and smartphones.", 19251:"Preview", 22102:"Cancelled - by customer request", 21918:"Remove from My eBooks", 21769:"Could not contact server. Please check your Internet connection.", 21809:"Web", 21827:"Smartphone", 18954:"Public bookshelf", 19694:"Discuss this patent", 21835:"This Google eBook includes flowing text, so you can adjust the font to read comfortably on an eReader.", 21862:"Scroll left", 19695:"Discuss this application", 19111:"\x3ca href\x3d\x22%1$s\x22 class\x3d\x22%2$s\x22\x3eView order\x3c/a\x3e", 21672:"Sample", 19154:"Read now", 21845:"This eBook includes scanned pages, so pages appear as they would in a printed book.", 21838:"This Google eBook includes flowing text  so you can adjust the font to read comfortably on the small screen of a smartphone.", 19689:"Less", 19113:"Credit card declined:", 18891:"Translate", 22206:"Gift Received", 22222:"Sorry, the publisher limits downloads of this book to {$number} devices or computers, and you have reached this limit. Please remove this book from other readers, wait a few minutes, and try again.", 21994:"Available on: \x3cb\x3e%1$s\x3c/b\x3e", 18849:"No preview available for this page."});</script><script type="text/javascript">function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: 'en',gaTrack: true,gaId: "UA-27188110-1"});}</script><script type="text/javascript" src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><link rel="canonical" href="http://www.google.com/patents/US6840954">
<meta property="og:url" content="http://www.google.com/patents/US6840954">
<meta name="title" content="Patent US6840954 - Systems and methods using vasoconstriction for improved thermal treatment of tissues">
<meta name="description" content="The present invention enhances the effectiveness of treatment of support tissue structures. Generally, such tissue structures support organs and hold the organs in their proper position for appropriate functioning. When such tissue structures become weak, hyper-elastic, and/or excessively lengthy, the organs of are no longer supported in their proper position. This often leads to physical manifestations such as incontinence, hernias, and the like. Remedies often involve thermal treatment of the support tissue structures, such as thermally inducted controlled shrinkage, contraction, or stiffening of the support tissue structure. To enhance such thermal treatment and diminish the possibility of undesirable heating and damage to nearby tissue surfaces, vasoconstrictive agents are used.">
<meta property="og:title" content="Patent US6840954 - Systems and methods using vasoconstriction for improved thermal treatment of tissues">
<meta property="og:type" content="book">
<meta property="og:site_name" content="Google Books">
<meta property="og:image" content="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;printsec=frontcover&amp;img=1&amp;zoom=1">
<link rel="image_src" href="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;printsec=frontcover&amp;img=1&amp;zoom=1">
<script>if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}@media all{.gb1{height:22;margin-right:.5em;vertical-align:top}#gbar{float:left}}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb4{color:#00c !important}.gbi .gb4{color:#dd8e27 !important}.gbf .gb4{color:#900 !important}
#gbar { padding:.3em .6em !important;}</style>
</head>
<body topmargin="3" marginheight="3">
<div id="gbar"><nobr><a class="gb1" href="http://www.google.com/search?hl=en&amp;sa=N&amp;tab=tw">Search</a> <a class="gb1" href="http://www.google.com/search?hl=en&amp;tbm=isch&amp;source=og&amp;sa=N&amp;tab=ti">Images</a> <a class="gb1" href="http://maps.google.com/maps?hl=en&amp;sa=N&amp;tab=tl">Maps</a> <a class="gb1" href="https://play.google.com/?hl=en&amp;tab=t8">Play</a> <a class="gb1" href="http://www.youtube.com/results?sa=N&amp;tab=t1">YouTube</a> <a class="gb1" href="http://news.google.com/nwshp?hl=en&amp;tab=tn">News</a> <a class="gb1" href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a class="gb1" href="https://drive.google.com/?tab=to">Drive</a> <a class="gb1" style="text-decoration:none" href="http://www.google.com/intl/en/options/"><u>More</u> &raquo;</a></nobr></div>
<div id="guser" width="100%"><nobr><span id="gbn" class="gbi"></span><span id="gbf" class="gbf"></span><span id="gbe"><a href="http://www.google.com/advanced_patent_search?ie=ISO-8859-1" class="gb4">Advanced Patent Search</a> | </span><a href="http://www.google.com/history/optout?hl=en" class="gb4">Web History</a> | <a target="_top" id="gb_70" href="https://www.google.com/accounts/Login?service=&amp;continue=http://www.google.com/patents%3Fhl%3Den&amp;hl=en" class="gb4">Sign in</a></nobr></div>
<div class="gbh" style="left:0"></div>
<div class="gbh" style="right:0"></div>
<div id="guser"><nobr></nobr></div>
<div style="clear:both;"></div>
<div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr>
<td class="logo"><a href="http://www.google.com/patents?ie=ISO-8859-1" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"></a></td>
<td><form action="http://www.google.com/search" name="f" id="vheadf" method="get">
<span id="hf"></span><input type="hidden" name="tbm" value="pts"><input type="hidden" name="tbo" value="1"><input type="hidden" name="hl" value="en"><table><tr>
<td><div class="inputs"><table><tr>
<td><div class="text-input">
<input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script>
</div></td>
<td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""></div></td>
</tr></table></div></td>
<td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search?ie=ISO-8859-1"><nobr>Advanced Patent Search</nobr></a></div></td>
</tr></table>
</form></td>
</tr></table></div>
<div class="kd-appbar">
<h2 class="kd-appname"><a href="/patents">Patents</a></h2>
<div class="kd-buttonbar left" id="left-toolbar-buttons">
<a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US6840954"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=UG8UAAAAEBAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS6840954&amp;usg=AFQjCNHAnEENwd77TwN2DMatiXOdLBamVQ" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/a/google.com/viewer?url=www.google.com/patents/US6840954.pdf"></a><a id="appbar-download-pdf-link" href="/patents/US6840954.pdf"></a>
</div>
<div class="kd-buttonbar right" id="right-toolbar-buttons"></div>
</div>
<div id="books-microdata" itemscope="" itemtype="http://schema.org/Book" itemid="http://www.google.com/patents/US6840954" style="display:none">
<span itemprop="description">The present invention enhances the effectiveness of treatment of support tissue structures. Generally, such tissue structures support organs and hold the organs in their proper position for appropriate functioning. When such tissue structures become weak, hyper-elastic, and/or excessively lengthy, the...</span><span itemprop="url">http://www.google.com/patents/US6840954?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US6840954 - Systems and methods using vasoconstriction for improved thermal treatment of tissues</span><img itemprop="image" src="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;printsec=frontcover&amp;img=1&amp;zoom=1" alt="Patent US6840954 - Systems and methods using vasoconstriction for improved thermal treatment of tissues" title="Patent US6840954 - Systems and methods using vasoconstriction for improved thermal treatment of tissues">
</div>
<table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr>
<td id="menu_td" class="menu_td"><div id="menu_container"><div class="menu" id="menu">
<div class="menu_content" style="margin-bottom:6px">
<div id="volume-info-sidebar">
<span class="gb-survey-link"></span><h1 class="gb-volume-title" dir="ltr">Systems and methods using vasoconstriction for improved thermal treatment of ...</h1>&nbsp;<span class="addmd">Timothy G. Dietz et al</span>
</div>
<table style="margin-bottom:4px"><tr class="sidebarnav">
<td class="sidebarcover"><a href="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;printsec=abstract&amp;zoom=4&amp;ie=ISO-8859-1"><img src="http://bks5.books.google.com/patents?id=UG8UAAAAEBAJ&amp;printsec=abstract&amp;img=1&amp;zoom=1&amp;sig=ACfU3U2fSrZfO-RGayzCVXXi6-GpvMhJLg" alt="Abstract" title="Abstract" width="102" border="1" id="summary-frontcover"></a></td>
<td class="sidebarlinks">
<span class="nolink">&rsaquo;&nbsp;Overview</span><br><a href="/patents/US6840954?printsec=abstract&amp;ie=ISO-8859-1">Abstract</a><br><a href="/patents/US6840954?printsec=drawing&amp;ie=ISO-8859-1">Drawings</a><br><a href="/patents/US6840954?printsec=description&amp;ie=ISO-8859-1">Description</a><br><a href="/patents/US6840954?printsec=claims&amp;ie=ISO-8859-1">Claims</a><br><span id="gb-atb-patents-plusone-container"></span>
</td>
</tr></table>
</div>
<div style="clear:both"></div>
<div style="margin-left:10px"><form action="/patents" id="search_form" style="margin:0px;padding:0px;" method="get"> <input type="hidden" name="ie" value="ISO-8859-1"><input type="hidden" name="id" value="UG8UAAAAEBAJ"><table cellpadding="0" cellspacing="0" class="swv-table"><tr>
<td width="100%" class="swv-td-search"><span><input id="search_form_input" type="text" maxlength="1024" class="text_flat swv-input-search" name="q" value="" title="Go" accesskey="i"></span></td>
<td class="swv-td-space">&nbsp;&nbsp;</td>
<td><input type="submit" value="Go"></td>
</tr></table>
<script type="text/javascript">if (window['_OC_autoDir']) {_OC_autoDir('search_form_input');}</script>
</form></div>
<div id="menu_scroll"><div id="metadata_content" class="menu_content"><div id="metadata_v"><div class="patent_bibdata"><p><b>Patent number</b>: 6840954<br><b>Filing date</b>: Dec 20, 2001<br><b>Issue date</b>: Jan 11, 2005<br><b>Application number</b>:&nbsp;<a href="/patents/US20030120326?ie=ISO-8859-1">10/029,000</a><br></p></div></div></div></div>
</div></div></td>
<td id="viewport_td">
<div class="vertical_module_list_row"><div id="overview" class="about_content"><div id="overview_v"><table id="summarytable" cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td valign="top">
<p class="patent_abstract_text">The present invention enhances the effectiveness of treatment of support tissue structures. Generally, such tissue structures support organs and hold the organs in their proper position for appropriate functioning. When such tissue structures become weak, hyper-elastic, and/or excessively lengthy, the organs of are no longer supported in their proper position. This often leads to physical manifestations such as incontinence, hernias, and the like. Remedies often involve thermal treatment of the support tissue structures, such as thermally inducted controlled shrinkage, contraction, or stiffening of the support tissue structure. To enhance such thermal treatment and diminish the possibility of undesirable heating and damage to nearby tissue surfaces, vasoconstrictive agents are used.</p>
<div class="patent_bibdata">
<b>Inventors</b>:&nbsp;<a href="http://www.google.com/search?tbo=p&amp;tbm=pts&amp;hl=en&amp;q=ininventor:%22Timothy+G.+Dietz%22">Timothy G. Dietz</a>, <a href="http://www.google.com/search?tbo=p&amp;tbm=pts&amp;hl=en&amp;q=ininventor:%22Stanley+Levy,+Jr.%22">Stanley Levy, Jr.</a><br><b>Original Assignee</b>:&nbsp;<a href="http://www.google.com/search?tbo=p&amp;tbm=pts&amp;hl=en&amp;q=inassignee:%22Solarant+Medical,+Inc.%22">Solarant Medical, Inc.</a><br><b>Primary Examiner</b>:&nbsp;Roy D. Gibson<br><b>Attorneys</b>:&nbsp;Townsend and Townsend and Crew LLP, Lynn M. Thompson<br><b>Current U.S. Classification</b>:&nbsp;<a href="http://www.google.com/url?id=UG8UAAAAEBAJ&amp;q=http://www.uspto.gov/web/patents/classification/uspc607/defs607.htm&amp;usg=AFQjCNFwjJlA8DE_357YYX435E_OoKAlYA#C607S096000">607/96</a>; <a href="http://www.google.com/url?id=UG8UAAAAEBAJ&amp;q=http://www.uspto.gov/web/patents/classification/uspc607/defs607.htm&amp;usg=AFQjCNFwjJlA8DE_357YYX435E_OoKAlYA#C607S099000">607/99</a>; <a href="http://www.google.com/url?id=UG8UAAAAEBAJ&amp;q=http://www.uspto.gov/web/patents/classification/uspc607/defs607.htm&amp;usg=AFQjCNFwjJlA8DE_357YYX435E_OoKAlYA#C607S104000">607/104</a><br><b>International Classification</b>:&nbsp;A61F/712; A61F/700<br><br><a href="http://www.google.com/url?id=UG8UAAAAEBAJ&amp;q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/6840954&amp;usg=AFQjCNEToDAgCeYhxzixth4tw4G37ne7uA">View patent at USPTO</a><br><a href="http://www.google.com/url?id=UG8UAAAAEBAJ&amp;q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D6840954&amp;usg=AFQjCNEmPhnxgBLEJXdzax_k40_kZLWb6w">Search USPTO Assignment Database</a><br><a href="http://www.google.com/url?id=UG8UAAAAEBAJ&amp;q=http://storage.googleapis.com/uspto-pair/applications/10029000.zip&amp;usg=AFQjCNEumnQksffEtrcJpWyggEucgMWQGg">Download USPTO Public PAIR data</a><br>
</div>
</td></tr></table></div></div></div>
<div class="vertical_module_list_row">
<h3 class="about_title">
<a name="patent_citations_anchor"></a>Citations</h3>
<div id="patent_citations" class="about_content"><div id="patent_citations_v"><table class="rel_patent" style="border-spacing:10px 0" cellpadding="4">
<tr>
<td class="rel_patent_header"><b>Cited Patent</b></td>
<td class="rel_patent_header"><b>Filing date</b></td>
<td class="rel_patent_header"><b>Issue date</b></td>
<td class="rel_patent_header"><b>Original Assignee</b></td>
<td class="rel_patent_header rel_patent_title"><b>Title</b></td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US728883?ie=ISO-8859-1">US728883</a></td>
<td valign="top" nowrap>Jul 29, 1902</td>
<td valign="top" nowrap>May 26, 1903</td>
<td valign="top"></td>
<td class="rel_patent_title" valign="top">ELECTROTHERMIC INSTRUMENT</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US4679561?ie=ISO-8859-1">US4679561</a></td>
<td valign="top" nowrap>May 20, 1985</td>
<td valign="top" nowrap>Jul 14, 1987</td>
<td valign="top">The United States of America as represented by the United States Department of Energy</td>
<td class="rel_patent_title" valign="top">Implantable apparatus for localized heating of tissue</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US4765331?ie=ISO-8859-1">US4765331</a></td>
<td valign="top" nowrap>Feb 10, 1987</td>
<td valign="top" nowrap>Aug 23, 1988</td>
<td valign="top">Circon Corporation</td>
<td class="rel_patent_title" valign="top">Electrosurgical device with treatment arc of less than 360 degrees</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US5201732?ie=ISO-8859-1">US5201732</a></td>
<td valign="top" nowrap>Apr 9, 1992</td>
<td valign="top" nowrap>Apr 13, 1993</td>
<td valign="top">Everest Medical Corporation</td>
<td class="rel_patent_title" valign="top">Bipolar sphincterotomy utilizing side-by-side parallel wires</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US5282799?ie=ISO-8859-1">US5282799</a></td>
<td valign="top" nowrap>Jul 11, 1991</td>
<td valign="top" nowrap>Feb 1, 1994</td>
<td valign="top">Everest Medical Corporation</td>
<td class="rel_patent_title" valign="top">Bipolar electrosurgical scalpel with paired loop electrodes</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US5423811?ie=ISO-8859-1">US5423811</a></td>
<td valign="top" nowrap>Mar 16, 1994</td>
<td valign="top" nowrap>Jun 13, 1995</td>
<td valign="top">Cardiac Pathways Corporation</td>
<td class="rel_patent_title" valign="top">Method for RF ablation using cooled electrode</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US5458596?ie=ISO-8859-1">US5458596</a></td>
<td valign="top" nowrap>May 6, 1994</td>
<td valign="top" nowrap>Oct 17, 1995</td>
<td valign="top">Dorsal Orthopedic Corporation</td>
<td class="rel_patent_title" valign="top">Method and apparatus for controlled contraction of soft tissue</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US5496312?ie=ISO-8859-1">US5496312</a></td>
<td valign="top" nowrap>Oct 7, 1993</td>
<td valign="top" nowrap>Mar 5, 1996</td>
<td valign="top">Valleylab Inc.</td>
<td class="rel_patent_title" valign="top">Impedance and temperature generator control</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US5514130?ie=ISO-8859-1">US5514130</a></td>
<td valign="top" nowrap>Oct 11, 1994</td>
<td valign="top" nowrap>May 7, 1996</td>
<td valign="top">Dorsal Med International</td>
<td class="rel_patent_title" valign="top">RF apparatus for controlled depth ablation of soft tissue</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US5569242?ie=ISO-8859-1">US5569242</a></td>
<td valign="top" nowrap>Feb 16, 1995</td>
<td valign="top" nowrap>Oct 29, 1996</td>
<td valign="top"></td>
<td class="rel_patent_title" valign="top">Method and apparatus for controlled contraction of soft tissue</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US6139571?ie=ISO-8859-1">US6139571</a></td>
<td valign="top" nowrap>Jul 9, 1997</td>
<td valign="top" nowrap>Oct 31, 2000</td>
<td valign="top">Fuller Research Corporation</td>
<td class="rel_patent_title" valign="top">Heated fluid surgical instrument</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US6162242?ie=ISO-8859-1">US6162242</a></td>
<td valign="top" nowrap>Jan 21, 1999</td>
<td valign="top" nowrap>Dec 19, 2000</td>
<td valign="top"></td>
<td class="rel_patent_title" valign="top">Selective photodynamic treatment</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US6283987?ie=ISO-8859-1">US6283987</a></td>
<td valign="top" nowrap>Jan 12, 1999</td>
<td valign="top" nowrap>Sep 4, 2001</td>
<td valign="top">SURx, Inc.</td>
<td class="rel_patent_title" valign="top">Ribbed electrodes and methods for their use</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US6470219?ie=ISO-8859-1">US6470219</a></td>
<td valign="top" nowrap>Oct 2, 2000</td>
<td valign="top" nowrap>Oct 22, 2002</td>
<td valign="top">Novasys Medical, Inc.</td>
<td class="rel_patent_title" valign="top">Apparatus and method for treating female urinary incontinence</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US6544248?ie=ISO-8859-1">US6544248</a></td>
<td valign="top" nowrap>Oct 8, 1999</td>
<td valign="top" nowrap>Apr 8, 2003</td>
<td valign="top">Starion Instruments Corporation</td>
<td class="rel_patent_title" valign="top">Device for suction-assisted lipectomy and method of using same</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US6562835?ie=ISO-8859-1">US6562835</a></td>
<td valign="top" nowrap>Oct 21, 1996</td>
<td valign="top" nowrap>May 13, 2003</td>
<td valign="top">Endo Pharmaceuticals Inc.</td>
<td class="rel_patent_title" valign="top">Method for the treatment of urinary incontinence</td>
</tr>
</table></div></div>
</div>
<div class="vertical_module_list_row">
<h3 class="about_title">
<a name="patent_referenced_by_anchor"></a>Referenced by</h3>
<div id="patent_referenced_by" class="about_content"><div id="patent_referenced_by_v"><table class="rel_patent" style="border-spacing:10px 0" cellpadding="4">
<tr>
<td class="rel_patent_header"><b>Citing Patent</b></td>
<td class="rel_patent_header"><b>Filing date</b></td>
<td class="rel_patent_header"><b>Issue date</b></td>
<td class="rel_patent_header"><b>Original Assignee</b></td>
<td class="rel_patent_header rel_patent_title"><b>Title</b></td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US7251531?ie=ISO-8859-1">US7251531</a></td>
<td valign="top" nowrap>Jan 30, 2004</td>
<td valign="top" nowrap>Jul 31, 2007</td>
<td valign="top">AMS Research Corporation</td>
<td class="rel_patent_title" valign="top">Heating method for tissue contraction</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US7476242?ie=ISO-8859-1">US7476242</a></td>
<td valign="top" nowrap>Jan 30, 2004</td>
<td valign="top" nowrap>Jan 13, 2009</td>
<td valign="top">AMS Research Corporation</td>
<td class="rel_patent_title" valign="top">Electrically heated/phase change probe temperature control</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US7833205?ie=ISO-8859-1">US7833205</a></td>
<td valign="top" nowrap>Oct 31, 2007</td>
<td valign="top" nowrap>Nov 16, 2010</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">Methods for treating meibomian gland dysfunction employing fluid jet</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US7976573?ie=ISO-8859-1">US7976573</a></td>
<td valign="top" nowrap>Jan 17, 2008</td>
<td valign="top" nowrap>Jul 12, 2011</td>
<td valign="top"></td>
<td class="rel_patent_title" valign="top">Inner eyelid heat and pressure treatment for treating meibomian gland dysfunction</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US7981095?ie=ISO-8859-1">US7981095</a></td>
<td valign="top" nowrap>Sep 29, 2006</td>
<td valign="top" nowrap>Jul 19, 2011</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">Methods for treating meibomian gland dysfunction employing fluid jet</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US7981145?ie=ISO-8859-1">US7981145</a></td>
<td valign="top" nowrap>Sep 29, 2006</td>
<td valign="top" nowrap>Jul 19, 2011</td>
<td valign="top">TearScience Inc.</td>
<td class="rel_patent_title" valign="top">Treatment of meibomian glands</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US7981146?ie=ISO-8859-1">US7981146</a></td>
<td valign="top" nowrap>Jan 17, 2008</td>
<td valign="top" nowrap>Jul 19, 2011</td>
<td valign="top">TearScience Inc.</td>
<td class="rel_patent_title" valign="top">Inner eyelid treatment for treating meibomian gland dysfunction</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US7981147?ie=ISO-8859-1">US7981147</a></td>
<td valign="top" nowrap>Jan 17, 2008</td>
<td valign="top" nowrap>Jul 19, 2011</td>
<td valign="top"></td>
<td class="rel_patent_title" valign="top">Outer eyelid heat and pressure treatment for treating meibomian gland dysfunction</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US8007524?ie=ISO-8859-1">US8007524</a></td>
<td valign="top" nowrap>Jan 17, 2008</td>
<td valign="top" nowrap>Aug 30, 2011</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">Heat treatment and heat loss reduction for treating meibomian gland dysfunction</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US8025689?ie=ISO-8859-1">US8025689</a></td>
<td valign="top" nowrap>Jun 23, 2010</td>
<td valign="top" nowrap>Sep 27, 2011</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">Method and apparatus for treating meibomian gland dysfunction</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US8083787?ie=ISO-8859-1">US8083787</a></td>
<td valign="top" nowrap>May 15, 2006</td>
<td valign="top" nowrap>Dec 27, 2011</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">Method and apparatus for treating meibomian gland dysfunction</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US8128673?ie=ISO-8859-1">US8128673</a></td>
<td valign="top" nowrap>Jan 17, 2008</td>
<td valign="top" nowrap>Mar 6, 2012</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">System for inner eyelid heat and pressure treatment for treating meibomian gland dysfunction</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US8128674?ie=ISO-8859-1">US8128674</a></td>
<td valign="top" nowrap>Jan 17, 2008</td>
<td valign="top" nowrap>Mar 6, 2012</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">System for outer eyelid heat and pressure treatment for treating meibomian gland dysfunction</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US8137390?ie=ISO-8859-1">US8137390</a></td>
<td valign="top" nowrap>Jan 17, 2008</td>
<td valign="top" nowrap>Mar 20, 2012</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">System for providing heat treatment and heat loss reduction for treating meibomian gland dysfunction</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US8170686?ie=ISO-8859-1">US8170686</a></td>
<td valign="top" nowrap>Mar 14, 2006</td>
<td valign="top" nowrap>May 1, 2012</td>
<td valign="top">Boston Scientific Scimed, Inc.</td>
<td class="rel_patent_title" valign="top">Heatable sling support for an anatomical location</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US8177781?ie=ISO-8859-1">US8177781</a></td>
<td valign="top" nowrap>May 10, 2006</td>
<td valign="top" nowrap>May 15, 2012</td>
<td valign="top">Novasys Medical, Inc.</td>
<td class="rel_patent_title" valign="top">Apparatus and methods for treating female urinary incontinence</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US8187310?ie=ISO-8859-1">US8187310</a></td>
<td valign="top" nowrap>Feb 11, 2011</td>
<td valign="top" nowrap>May 29, 2012</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">Method and apparatus for treating gland dysfunction</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US8187311?ie=ISO-8859-1">US8187311</a></td>
<td valign="top" nowrap>Feb 11, 2011</td>
<td valign="top" nowrap>May 29, 2012</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">Method and apparatus for treating gland dysfunction</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/US8202242?ie=ISO-8859-1">US8202242</a></td>
<td valign="top" nowrap>Jul 16, 2008</td>
<td valign="top" nowrap>Jun 19, 2012</td>
<td valign="top">Covidien AG</td>
<td class="rel_patent_title" valign="top">Method of using vasoconstrictive agents during energy-based tissue therapy</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/USD613408?ie=ISO-8859-1">USD613408</a></td>
<td valign="top" nowrap>Feb 6, 2008</td>
<td valign="top" nowrap>Apr 6, 2010</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">Eye treatment head gear</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/USD614303?ie=ISO-8859-1">USD614303</a></td>
<td valign="top" nowrap>Feb 6, 2008</td>
<td valign="top" nowrap>Apr 20, 2010</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">Eye treatment apparatus</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/USD617443?ie=ISO-8859-1">USD617443</a></td>
<td valign="top" nowrap>Feb 6, 2008</td>
<td valign="top" nowrap>Jun 8, 2010</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">Eye treatment goggles</td>
</tr>
<tr>
<td valign="top" nowrap><a href="/patents/USD638128?ie=ISO-8859-1">USD638128</a></td>
<td valign="top" nowrap>Oct 6, 2009</td>
<td valign="top" nowrap>May 17, 2011</td>
<td valign="top">TearScience, Inc.</td>
<td class="rel_patent_title" valign="top">Ocular device design</td>
</tr>
</table></div></div>
</div>
<div class="vertical_module_list_row">
<h3 class="about_title">
<a name="patent_claims_anchor"></a>Claims</h3>
<div id="patent_claims" class="about_content"><div id="patent_claims_v">
<p>1. A method of treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">introducing a vasoconstrictive agent supported by a carrier to the target tissue to form a vasoconstricted target tissue, wherein introducing the vasoconstrictive agent comprises applying the agent to a surface of the target tissue, by holding the carrier against the target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">positioning a probe having a heat-applying element so that the element is aligned with the vasoconstricted target tissue; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">energizing the probe to heat a portion of the vasoconstricted target tissue.</dd></dl>
<p>2. A method as in claim 1, wherein the vasoconstrictive agent comprises epinephrme.</p>
<p>3. A method as in claim 1, wherein the vasoconstrictive agent is ionized and further comprising electrically stimulating the agent and/or target tissue to assist absorption of the agent.</p>
<p>4. A method as in claim 1, further comprising ultrasonically stimulating the agent and/or target tissue to assist absorption of the agent.</p>
<p>5. A method as in claim 1, wherein introducing the vasoconstrictive agent further comprises injecting the agent into the target tissue.</p>
<p>6. A method as in claim 1, wherein energizing the probe comprises providing radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids, or ultrasound energy.</p>
<p>7. A method as in claim 1, wherein the heat applying elements comprise first and second electrodes, and wherein energizing the probe comprises applying an electrical potential across the first and second electrodes to heat the portion of the vasoconstricted target tissue.</p>
<p>8. A method as in claim 1, wherein the target tissue comprises a pelvic support tissue and wherein energizing the probe to heat the portion of the vasoconstricted target tissue reduces urinary incontinence.</p>
<p>9. A method as in claim 1, wherein the heat applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments, said method further comprising cooling a portion of the vasoconstricted target tissue adjacent the probe with the cooled electrode segments.</p>
<p>10. A method as in claim 1, positioning another probe having at least one heat-applying element so that the vasoconstricted target tissue is disposed between the heat-applying elements of the probe and the another probe.</p>
<p>11. A method as in claim 10, wherein the target tissue comprises the endopelvic fascia, the probe comprises a vaginal probe and positioning the probe comprises inserting the vaginal probe into a vagina, and the another probe comprises a urethral probe and positioning the another probe comprises inserting the urethral probe into a urethra.</p>
<p>12. A system for treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">a vasoconstrictive agent comprising epinephrine and having a form of a liquid or paste, the agent absorbable by at least a portion of the target tissue to form a vasoconstricted target tissue and the agent having a concentration in the range of 1 mg agent per 25 ml solution to 1 mg agent per 200 ml solution;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a carrier comprising gauze upon or within which the vasoconstrictive agent is disposed; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a probe having a proximal end, a distal end and at least one heat-applying element near its distal end positionable near the vasoconstricted target tissue so that energizing the probe heats a portion of the vasoconstricted target tissue.</dd></dl>
<p>13. A system as in claim 12, wherein the agent is ionizable.</p>
<p>14. A system as in claim 12, wherein heat-applying elements deliver radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids, or ultrasound energy.</p>
<p>15. A system as in claim 14, wherein the heat-applying elements comprise electrodes.</p>
<p>16. A system as in claim 15, wherein the electrodes deliver a maximum power of 50 watts.</p>
<p>17. A system as in claim 15, wherein the heat-applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments.</p>
<p>18. A system as in claim 12, further comprising another probe having a proximal end, a distal end and at least one heat-applying element near its distal end positionable near the vasoconstricted target tissue so that the vasoconstricted target tissue is disposed between the heat-applying elements of the probe and the another probe.</p>
<p>19. A system as in claim 18, wherein the target tissue comprises the endopelvic fascia, the probe comprises a vaginal probe positionable within a vagina and the another probe comprises a urethral probe positionable within a urethra.</p>
<p>20. A system as in claim 12, further comprising a guide which is engageable with the probe to maintain the probe at a position relative to the guide.</p>
<p>21. A method to treat urinary stress incontinence, the method comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">introducing a vasoconstrictive agent to a pelvic support tissue which supports the bladder or urethra to form a vasoconstricted tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">aligning a probe with the vasoconstricted tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">energizing the probe to heat a portion of the vasoconstricted tissue so that the tissue is altered reducing incontinence.</dd></dl>
<p>22. A method as in claim 21, wherein the vasoconstrictive agent comprises epinephrmne.</p>
<p>23. A method as in claim 21, wherein introducing the vasoconstrictive agent comprises applying the agent to the vaginal mucosa.</p>
<p>24. A method as in claim 23, wherein aligning the probe comprises inserting the probe within a vagina.</p>
<p>25. A method as in claim 24, wherein the probe has a proximal end, a distal end, and at least one heat-applying element near its distal end, said method further comprising aligning the probe so that its heat-applying element is aligned with the vaginal mucosa.</p>
<p>26. A method as in claim 23, wherein energizing the probe heats the endopelvic fascia.</p>
<p>27. A method as in claim 21, wherein the probe comprises heat applying elements and wherein energizing the probe comprises providing radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids, or ultrasound energy with the use of the heat-applying elements.</p>
<p>28. A method as in claim 27, wherein the heat applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments, said method further comprising cooling the vasoconstricted tissue adjacent the probe with the cooled electrode segments.</p>
<p>29. A method as in claim 21, further comprising positioning another probe having heat-applying elements near the vasoconstricted tissue so that the portion of the vasoconstricted tissue is disposed between the heat applying elements of the probe and the another probe.</p>
<p>30. A method as in claim 29, further comprising energizing the another probe while energizing the probe to heat the portion of the vasoconstricted tissue disposed between the heat applying elements of the probe and the another probe.</p>
<p>31. A method as in claim 29, wherein the probe comprises a vaginal probe and aligning the probe comprises inserting the vaginal probe into a vagina, and the another probe comprises a urethral probe and aligning the another probe comprises inserting the urethral probe into a urethra.</p>
<p>32. A method as in claim 21, further comprising introducing a guide to a urethra.</p>
<p>33. A method as in claim 32, further comprising attaching the probe to the guide to maintain the probe at a position relative to the guide.</p>
<p>34. A kit comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">a vasoconstrictive agent;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a carrier which is capable of carrying the vasoconstrictive agent;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a guide; and</dd></dl>
<p></p>
<dl>
<dd style="margin-left:1em;">instructions for use setting forth a method comprising the steps of</dd>
<dd style="margin-left:1em;">introducing the vasoconstrictive agent to a target tissue so that the agent is absorbed to form a vasoconstricted target tissue; and</dd>
<dd style="margin-left:1em;">energizing a probe to heat a portion of the vasoconstricted target tissue.</dd>
</dl>
<p>35. A kit as in claim 34, further comprising the probe.</p>
<p>36. A kit as in claim 34, wherein the vasoconstrictive agent comprises epinephrine.</p>
<p>37. A kit as in claim 34, further comprising a syringe within which the vasoconstrictive agent is loadable.</p>
<p>38. A method of treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">introducing a vasoconstrictive agent to the target tissue, wherein the target tissue comprises a pelvic support tissue, to form a vasoconstricted target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">positioning a probe having a heat-applying element so that the element is aligned with the vasoconstricted target tissue; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">energizing the probe to heat a portion of the vasoconstricted target tissue which reduces urinary incontinence.</dd></dl>
<p>39. A method as in claim 38, wherein the vasoconstrictive agent comprises epinephrine.</p>
<p>40. A method as in claim 38, wherein introducing the vasoconstrictive agent comprises applying the agent to a surface of the target tissue.</p>
<p>41. A method as in claim 40, wherein the agent is supported by a carrier and applying the agent to the surface comprises holding the carrier against the target tissue.</p>
<p>42. A method as in claim 40, wherein the vasoconstrictive agent is ionized and further comprising electrically stimulating the agent and/or target tissue to assist absorption of the agent.</p>
<p>43. A method as in claim 46, further comprising ultrasonically stimulating the agent and/or target tissue to assist absorption of the agent.</p>
<p>44. A method as in claim 38, wherein introducing the vasoconstrictive agent comprises injecting the agent into the target tissue.</p>
<p>45. A method as in claim 38, wherein energizing the probe comprises providing radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids, or ultrasound energy.</p>
<p>46. A method as in claim 38, wherein the heat applying elements comprise first and second electrodes, and wherein energizing the probe comprises applying an electrical potential across the first and second electrodes to heat the portion of the vasoconstricted target tissue.</p>
<p>47. A method as in claim 38, wherein the heat applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments, said method further comprising cooling a portion of the vasoconstricted target tissue adjacent the probe with the cooled electrode segments.</p>
<p>48. A method as in claim 38, positioning another probe having at least one heat-applying element so that the vasoconstricted target tissue is disposed between the heat-applying elements of the probe and the another probe.</p>
<p>49. A method as in claim 48, where in the target tissue comprises the endopelvic fascia, the probe comprises a vaginal probe and positioning the probe comprises inserting the vaginal probe into a vagina, and the another probe comprises a urethral probe and positioning the another probe comprises inserting the urethral probe into a urethra.</p>
<p>50. A method of treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">introducing a vasoconstrictive agent to the target tissue to form a vasoconstricted target tissue, wherein introducing the vasoconstrictive agent comprises injecting the agent into the target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">positioning a probe having a heat-applying element so that the element is aligned with the vasoconstricted target tissue, wherein the heat applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">energizing the probe to heat a portion of the vasoconstricted target tissue; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">cooling a portion of the vasoconstricted target tissue adjacent the probe with the cooled electrode segments.</dd></dl>
<p>51. A method as in claim 50, wherein the vasoconstrictive agent comprises epinephrine.</p>
<p>52. A method as in claim 50, wherein the vasoconstrictive agent is ionized and further comprising electrically stimulating the agent and/or target tissue to assist absorption of the agent.</p>
<p>53. A method as in claim 50, wherein the heat applying elements comprise first and second electrodes, and wherein energizing the probe comprises applying an electrical potential across the first and second electrodes to heat the portion of the vasoconstricted target tissue.</p>
<p>54. A method as in claim 50, wherein the target tissue comprises a pelvic support tissue and wherein energizing the probe to heat the portion of the vasoconstricted target tissue reduces urinary incontinence.</p>
<p>55. A method of treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">introducing a vasoconstrictive agent to the target tissue to form a vasoconstricted target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">positioning a probe having a heat-applying element so that the element is aligned with the vasoconstricted target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">energizing the probe to heat a portion of the vasoconstricted target tissue; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">positioning another probe having at least one heat-applying element so that the vasoconstricted target tissue is disposed between the heat-applying elements of the probe and the another probe.</dd></dl>
<p>56. A system for treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">a vasoconstrictive agent comprising epinephrine, wherein the agent is absorbable by at least a portion of the target tissue to form a vasoconstricted target tissue and the agent is ionizable, wherein the vasoconstrictive agent has a form of a liciuid or paste;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a carrier upon or within which the vasoconstrictive agent is disposed, wherein the carrier comprises gauze; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a probe having a proximal end, a distal end and at least one heat-applying element near its distal end positionable near the vasoconstricted target tissue so that energizing the probe heats a portion of the vasoconstricted target tissue.</dd></dl>
<p>57. A system as in claim 56, wherein the agent has a concentration in the range of 1 mg agent per 25 ml solution to 1 mg agent per 200 ml solution.</p>
<p>58. A system as in claim 56, wherein heat-applying elements deliver radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids, or ultrasound energy.</p>
<p>59. A system as in claim 58, wherein the heat-applying elements comprise electrodes.</p>
<p>60. A system as in claim 59, wherein the electrodes deliver a maximum power of 50 watts.</p>
<p>61. A system as in claim 59, wherein the heat-applying elements comprise a plurality of electrode segments and the probe further comprises cooling fluid system which cools the electrode segments.</p>
<p>62. A system for treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">a vasoconstrictive agent absorbable by at least a portion of the target tissue to form a vasoconstricted target tissue, wherein the vasoconstrictive agent has a form of a liquid or paste;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a carrier upon or within which the vasoconstrictive agent is disposed, wherein the carrier comprises gauze; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a probe having a proximal end, a distal end and at least one heat-applying element near its distal end positionable near the vasoconstricted target tissue so that energizing the probe heats a portion of the vasoconstricted target tissue.</dd></dl>
<p>63. A system as in claim 62, wherein the vasoconstrictive agent is comprises epinephrine.</p>
<p>64. A system as in claim 63, wherein the agent has a concentration in the range of 1 mg agent per 25 ml solution to 1 mg agent per 200 ml solution.</p>
<p>65. A system as in claim 62, wherein the agent is ionizable.</p>
<p>66. A system as in claim 62, wherein heat-applying elements deliver radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids, or ultrasound energy.</p>
<p>67. A system as in claim 66, wherein the heat-applying elements comprise electrodes.</p>
<p>68. A system as in claim 67, wherein the electrodes deliver a maximum power of 50 watts.</p>
<p>69. A system as in claim 67, wherein the heat-applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments.</p>
<p>70. A system as in claim 62, further comprising a guide which is engageable with the probe to maintain the probe at a position relative to the guide.</p>
<p>71. A system for treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">a vasoconstrictive agent absorbable by at least a portion of the target tissue to form a vasoconstricted target tissue; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a probe having a proximal end, a distal end and at least one heat-applying element comprising a plurality of electrode segments near its distal end positionable near the vasoconstricted target tissue so that energizing the probe heats a portion of the vasoconstricted target tissue, the at least one heat-applying element delivering radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids or ultrasound energy, and the probe further comprises a cooling fluid system which cools the electrode segments.</dd></dl>
<p>72. A system as in claim 71, wherein the vasoconstrictive agent is comprises epinephrine.</p>
<p>73. A system as in claim 71, further comprising a carrier upon or within which the vasoconstrictive agent is disposed.</p>
<p>74. A system as in claim 71, further comprising a needle and a syringe within which the vasoconstrictive agent is loaded.</p>
<p>75. A system for treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">a vasoconstrictive agent absorbable by at least a portion of the target tissue to form a vasoconstricted target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a probe having a proximal end, a distal end and at least one heat-applying element near its distal end positionable near the vasoconstricted target tissue so that energizing the probe heats a portion of the vasoconstricted target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">another probe having a proximal end, a distal end and at least one heat-applying element near its distal end positionable near the vasoconstricted target tissue so that the vasoconstricted target tissue is disposed between the heat-applying elements of the probe and the another probe.</dd></dl>
<p>76. A system for treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">a vasoconstrictive agent absorbable by at least a portion of the target tissue to form a vasoconstricted target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a probe having a proximal end, a distal end and at least one heat-applying element near its distal end positionable near the vasoconstricted target tissue so that energizing the probe heats a portion of the vasoconstricted target tissue; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a guide which is engageable with the probe to maintain the probe at a position relative to the guide.</dd></dl>
<p>77. A system as in claim 76, wherein the vasoconstrictive agent is comprises epinephrine.</p>
<p>78. A system as in claim 76, further comprising a carrier upon or within which the vasoconstrictive agent is disposed.</p>
<p>79. A system as in claim 76, further comprising a needle and a syringe within which the vasoconstrictive agent is loaded.</p>
<p>80. A method of treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">introducing a vasoconstrictive agent which is ionized to the target tissue to form a vasoconstricted target tissue, wherein introducing the vasoconstrictive agent comprises applying the agent to a surface of the target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">positioning a probe having a heat-applying element so that the element is aligned with the vasoconstricted target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">energizing the probe to heat a portion of the vasoconstricted target tissue; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">electrically stimulating the agent and/or target tissue to assist absorption of the agent.</dd></dl>
<p>81. A method as in claim 80, wherein the vasoconstrictive agent comprises epinephrine.</p>
<p>82. A method as in claim 80, wherein the agent is supported by a carrier and applying the agent to the surface comprises holding the carrier against the target tissue.</p>
<p>83. A method as in claim 80, further comprising ultrasonically stimulating the agent and/or target tissue to assist absorption of the agent.</p>
<p>84. A method as in claim 80, wherein introducing the vasoconstrictive agent further comprises injecting the agent into the target tissue.</p>
<p>85. A method as in claim 80, wherein energizing the probe comprises providing radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids, or ultrasound energy.</p>
<p>86. A method as in claim 80, wherein the heat applying elements comprise first and second electrodes, and wherein energizing the probe comprises applying an electrical potential across the first and second electrodes to heat the portion of the vasoconstricted target tissue.</p>
<p>87. A method as in claim 80, wherein the target tissue comprises a pelvic support tissue and wherein energizing the probe to heat the portion of the vasoconstricted target tissue reduces urinary incontinence.</p>
<p>88. A method as in claim 80, wherein the heat applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments, said method further comprising cooling a portion of the vasoconstricted target tissue adjacent the probe with the cooled electrode segments.</p>
<p>89. A method as in claim 80, positioning another probe having at least one heat-applying element so that the vasoconstricted target tissue is disposed between the heat-applying elements of the probe and the another probe.</p>
<p>90. A method as in claim 89, wherein the target tissue comprises the endopelvic fascia, the probe comprises a vaginal probe and positioning the probe comprises inserting the vaginal probe into a vagina, and the another probe comprises a urethral probe and positioning the another probe comprises inserting the urethral probe into a urethra.</p>
<p>91. A method of treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">introducing a vasoconstrictive agent to the target tissue to form a vasoconstricted target tissue, wherein introducing the vasoconstrictive agent comprises applying the agent to a surface of the target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">positioning a probe having a heat-applying element so that the element is aligned with the vasoconstricted target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">energizing the probe to heat a portion of the vasoconstricted target tissue; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">ultrasonically stimulating the agent and/or target tissue to assist absorption of the agent.</dd></dl>
<p>92. A method as in claim 91, wherein the vasoconstrictive agent comprises epinephrine.</p>
<p>93. A method as in claim 91, wherein the agent is supported by a carrier and applying the agent to the surface comprises holding the carrier against the target tissue.</p>
<p>94. A method as in claim 91, wherein the vasoconstrictive agent is ionized and further comprising electrically stimulating the agent and/or target tissue to assist absorption of the agent.</p>
<p>95. A method as in claim 91, wherein introducing the vasoconstrictive agent further comprises injecting the agent into the target tissue.</p>
<p>96. A method as in claim 91, wherein energizing the probe comprises providing radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids, or ultrasound energy.</p>
<p>97. A method as in claim 91, wherein the heat applying elements comprise first and second electrodes, and wherein energizing the probe comprises applying an electrical potential across the first and second electrodes to heat the portion of the vasoconstricted target tissue.</p>
<p>98. A method as in claim 91, wherein the target tissue comprises a pelvic support tissue and wherein energizing the probe to heat the portion of the vasoconstricted target tissue reduces urinary incontinence.</p>
<p>99. A method as in claim 91, wherein the heat applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments, said method further comprising cooling a portion of the vasoconstricted target tissue adjacent the probe with the cooled electrode segments.</p>
<p>100. A method as in claim 91, positioning another probe having at least one heat-applying element so that the vasoconstricted target tissue is disposed between the heat-applying elements of the probe and the another probe.</p>
<p>101. A method as in claim 100, wherein the target tissue comprises the endopelvic fascia, the probe comprises a vaginal probe and positioning the probe comprises inserting the vaginal probe into a vagina, and the another probe comprises a urethral probe and positioning the another probe comprises inserting the urethral probe into a urethra.</p>
<p>102. A method of treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">introducing a vasoconstrictive agent to the target tissue to form a vasoconstricted target tissue, wherein introducing the vasoconstrictive agent comprises applying the agent to a surface of the target tissue and injecting the agent into the target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">positioning a probe having a heat-applying element so that the element is aligned with the vasoconstricted target tissue; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">energizing the probe to heat a portion of the vasoconstricted target tissue.</dd></dl>
<p>103. A method as in claim 102, wherein the vasoconstrictive agent comprises epinephrmne.</p>
<p>104. A method as in claim 102, applying the agent to the surface comprises holding a carrier supporting the agent against the target tissue.</p>
<p>105. A method as in claim 102, wherein the vasoconstrictive agent is ionized and further comprising electrically stimulating the agent and/or target tissue to assist absorption of the agent.</p>
<p>106. A method as in claim 102, further comprising ultrasonically stimulating the agent and/or target tissue to assist absorption of the agent.</p>
<p>107. A method as in claim 102, wherein energizing the probe comprises providing radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids, or ultrasound energy.</p>
<p>108. A method as in claim 102, wherein the heat applying elements comprise first and second electrodes, and wherein energizing the probe comprises applying an electrical potential across the first and second electrodes to heat the portion of the vasoconstricted target tissue.</p>
<p>109. A method as in claim 102, wherein the target tissue comprises a pelvic support tissue and wherein energizing the probe to heat the portion of the vasoconstricted target tissue reduces urinary incontinence.</p>
<p>110. A method as in claim 102, wherein the heat applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments, said method further comprising cooling a portion of the vasoconstricted target tissue adjacent the probe with the cooled electrode segments.</p>
<p>111. A method as in claim 102, positioning another probe having at least one heat-applying element so that the vasoconstricted target tissue is disposed between the heat-applying elements of the probe and the another probe.</p>
<p>112. A method as in claim 111, wherein the target tissue comprises the endopelvic fascia, the probe comprises a vaginal probe and positioning the probe comprises inserting the vaginal probe into a vagina, and the another probe comprises a urethral probe and positioning the another probe comprises inserting the urethral probe into a urethra.</p>
<p>113. A method of treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">introducing a vasoconstrictive agent to the target tissue to form a vasoconstricted target tissue wherein the target tissue comprises a pelvic support tissue, wherein introducing the vasoconstrictive agent comprises applying the agent to a surface of the target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">positioning a probe having a heat-applying element so that the element is aligned with the vasoconstricted target tissue; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">energizing the probe to heat a portion of the vasoconstricted target tissue which reduces urinary incontinence.</dd></dl>
<p>114. A method as in claim 113, wherein the vasoconstrictive agent comprises epinephrine.</p>
<p>115. A method as in claim 113, wherein the agent is supported by a carrier and applying the agent to the surface comprises holding the carrier against the target tissue.</p>
<p>116. A method as in claim 113, wherein the vasoconstrictive agent is ionized and further comprising electrically stimulating the agent and/or target tissue to assist absorption of the agent.</p>
<p>117. A method as in claim 113, further comprising ultrasonically stimulating the agent and/or target tissue to assist absorption of the agent.</p>
<p>118. A method as in claim 113, wherein introducing the vasoconstrictive agent further comprises injecting the agent into the target tissue.</p>
<p>119. A method as in claim 113, wherein energizing the probe comprises providing radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids, or ultrasound energy.</p>
<p>120. A method as in claim 113, wherein the heat applying elements comprise first and second electrodes, and wherein energizing the probe comprises applying an electrical potential across the first and second electrodes to heat the portion of the vasoconstricted target tissue.</p>
<p>121. A method as in claim 113, wherein the heat applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments, said method further comprising cooling a portion of the vasoconstricted target tissue adjacent the probe with the cooled electrode segments.</p>
<p>122. A method as in claim 113, positioning another probe having at least one heat-applying element so that the vasoconstricted target tissue is disposed between the heat-applying elements of the probe and the another probe.</p>
<p>123. A method as in claim 122, wherein the target tissue comprises the endopelvic fascia, the probe comprises a vaginal probe and positioning the probe comprises inserting the vaginal probe into a vagina, and the another probe comprises a urethral probe and positioning the another probe comprises inserting the urethral probe into a urethra.</p>
<p>124. A method of treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">introducing a vasoconstrictive agent to the target tissue to form a vasoconstricted target tissue, wherein introducing the vasoconstrictive agent comprises applying the agent to a surface of the target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">positioning a probe having a heat-applying element so that the element is aligned with the vasoconstricted target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">positioning another probe having at least one heat-applying element so that the vasoconstricted target tissue is disposed between the heat-applying elements of the probe and the another probe; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">energizing the probe to heat a portion of the vasoconstricted target tissue.</dd></dl>
<p>125. A method as in claim 124, wherein the vasoconstrictive agent comprises epinephrine.</p>
<p>126. A method as in claim 124, wherein the agent is supported by a carrier and applying the agent to the surface comprises holding the carrier against the target tissue.</p>
<p>127. A method as in claim 124, wherein the vasoconstrictive agent is ionized and further comprising electrically stimulating the agent and/or target tissue to assist absorption of the agent.</p>
<p>128. A method as in claim 124, further comprising ultrasonically stimulating the agent and/or target tissue to assist absorption of the agent.</p>
<p>129. A method as in claim 124, wherein introducing the vasoconstrictive agent further comprises injecting the agent into the target tissue.</p>
<p>130. A method as in claim 124, wherein energizing the probe comprises providing radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids, or ultrasound energy.</p>
<p>131. A method as in claim 124, wherein the heat applying elements comprise first and second electrodes, and wherein energizing the probe comprises applying an electrical potential across the first and second electrodes to heat the portion of the vasoconstricted target tissue.</p>
<p>132. A method as in claim 124, wherein the target tissue comprises a pelvic support tissue and wherein energizing the probe to heat the portion of the vasoconstricted target tissue reduces urinary incontinence.</p>
<p>133. A method as in claim 124, wherein the heat applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments, said method further comprising cooling a portion of the vasoconstricted target tissue adjacent the probe with the cooled electrode segments.</p>
<p>134. A method as in claim 124, wherein the target tissue comprises the endopelvic fascia, the probe comprises a vaginal probe and positioning the probe comprises inserting the vaginal probe into a vagina, and the another probe comprises a urethral probe and positioning the another probe comprises inserting the urethral probe into a urethra.</p>
<p>135. A system for treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">a vasoconstrictive agent comprising epinephrine, the agent absorbable by at least a portion of the target tissue to form a vasoconstricted target tissue, wherein the target tissue comprises the endopelvic fascia, and the agent has a concentration in the range of 1 mg agent per 25 ml solution to 1 mg agent per 200 ml solution;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a probe having a proximal end, a distal end and at least one heat-applying element near its distal end positionable near the vasoconstricted target tissue so that energizing the probe heats a portion of the vasoconstricted target tissue, wherein the probe comprises a vaginal probe positionable within a vagina; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">another probe having a proximal end, a distal end and at least one heat-applying element near its distal end positionable near the vasoconstricted target tissue so that the vasoconstricted target tissue is disposed between the heat-applying elements of the probe and the another probe, wherein the another probe comprises a urethral probe positionable within a urethra.</dd></dl>
<p>136. A system as in claim 135, wherein the agent is ionizable.</p>
<p>137. A system as in claim 135, further comprising a carrier upon or within which the vasoconstrictive agent is disposed.</p>
<p>138. A system as in claim 137, wherein the vasoconstrictive agent has a form of a liquid or paste and the carrier comprises gauze.</p>
<p>139. A system as in claim 135, further comprising a needle and a syringe within which the vasoconstrictive agent is loaded.</p>
<p>140. A system as in claim 135, wherein heat-applying elements deliver radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids, or ultrasound energy.</p>
<p>141. A system as in claim 140, wherein the heat-applying elements comprise electrodes.</p>
<p>142. A system as in claim 141, wherein the electrodes deliver a maximum power of 50 watts.</p>
<p>143. A system as in claim 141, wherein the heat-applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments.</p>
<p>144. A system as in claim 135, further comprising a guide which is engageable with the probe to maintain the probe at a position relative to the guide.</p>
<p>145. A system for treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">a vasoconstrictive agent comprising epinephrine, the agent absorbable by at least a portion of the target tissue to form a vasoconstricted target tissue and the agent having a concentration in the range of 1 mg agent per 25 ml solution to 1 mg agent per 200 ml solution;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a probe having a proximal end, a distal end and at least one heat-applying element near its distal end positionable near the vasoconstricted target tissue so that energizing the probe heats a portion of the vasoconstricted target tissue; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a guide which is engageable with the probe to maintain the probe at a position relative to the guide.</dd></dl>
<p>146. A system as in claim 145, wherein the agent is ionizable.</p>
<p>147. A system as in claim 145, further comprising a carrier upon or within which the vasoconstrictive agent is disposed.</p>
<p>148. A system as in claim 147, wherein the vasoconstrictive agent has a form of a liquid or paste and the carrier comprises gauze.</p>
<p>149. A system as in claim 145, further comprising a needle and a syringe within which the vasoconstrictive agent is loaded.</p>
<p>150. A system as in claim 145, wherein heat-applying elements deliver radiofrequency energy, microwave energy, light or laser energy, electrical resistance heating, heated fluids, or ultrasound energy.</p>
<p>151. A system as in claim 150, wherein the heat-applying elements comprise electrodes.</p>
<p>152. A system as in claim 151, wherein the electrodes deliver a maximum power of 50 watts.</p>
<p>153. A system as in claim 151, wherein the heat-applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments.</p>
<p>154. A system as in claim 145, further comprising another probe having a proximal end, a distal end and at least one heat-applying element near its distal end positionable near the vasoconstricted target tissue so that the vasoconstricted target tissue is disposed between the heat-applying elements of the probe and the another probe.</p>
<p>155. A system as in claim 154, wherein the target tissue comprises the endopelvic fascia, the probe comprises a vaginal probe positionable within a vagina and the another probe comprises a urethral probe positionable within a urethra.</p>
<p>156. A method of treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">introducing a vasoconstrictive agent to the target tissue to form a vasoconstricted target tissue, wherein the target tissue comprises a pelvic support tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">positioning a probe having a heat-applying element so that the element is aligned with the vasoconstricted target tissue, wherein the heat applying elements comprise a plurality of electrode segments and the probe further comprises a cooling fluid system which cools the electrode segments;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">energizing the probe to heat a portion of the vasoconstricted target tissue which reduces urinary incontinence; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">cooling a portion of the vasoconstricted target tissue adjacent the probe with the cooled electrode segments.</dd></dl>
<p>157. A system for treating a target tissue of a patient body comprising:</p>
<p></p>
<dl><dd style="margin-left:1em;">a vasoconstrictive agent absorbable by at least a portion of the target tissue to form a vasoconstricted target tissue;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a carrier upon or within which the vasoconstrictive agent is disposed;</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a probe having a proximal end, a distal end and at least one heat-applying element near its distal end positionable near the vasoconstricted target tissue so that energizing the probe heats a portion of the vasoconstricted target tissue; and</dd></dl>
<p></p>
<dl><dd style="margin-left:1em;">a guide which is engageable with the probe to maintain the probe at a position relative to the guide.</dd></dl>
</div></div>
</div>
<div class="vertical_module_list_row">
<h3 class="about_title">
<a name="selected_pages_anchor"></a>Drawings</h3>
<div id="selected_pages" class="about_content"><div id="selected_pages_v">
<div class="selectedpagesthumbnail">
<a href="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA2&amp;ie=ISO-8859-1&amp;source=gbs_selected_pages&amp;cad=4"><img src="http://bks5.books.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA2&amp;img=1&amp;zoom=1&amp;sig=ACfU3U1VQFT8-IOxAEVBVdIC8B7Ua_4KXA" alt="Drawings" title="Drawings" height="160" border="1"></a><br><a class="primary" href="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA2&amp;ie=ISO-8859-1&amp;source=gbs_selected_pages&amp;cad=4">Drawings</a>
</div>
<div class="selectedpagesthumbnail">
<a href="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA3&amp;ie=ISO-8859-1&amp;source=gbs_selected_pages&amp;cad=4"><img src="http://bks5.books.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA3&amp;img=1&amp;zoom=1&amp;sig=ACfU3U0Q6uefalXt4O-n6ulQ-A41iLSc4g" alt="Drawings" title="Drawings" height="160" border="1"></a><br><a class="primary" href="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA3&amp;ie=ISO-8859-1&amp;source=gbs_selected_pages&amp;cad=4">Drawings</a>
</div>
<div class="selectedpagesthumbnail">
<a href="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA4&amp;ie=ISO-8859-1&amp;source=gbs_selected_pages&amp;cad=4"><img src="http://bks5.books.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA4&amp;img=1&amp;zoom=1&amp;sig=ACfU3U12IJr8h6RTqU7-48YihM3P9CmeCQ" alt="Drawings" title="Drawings" height="160" border="1"></a><br><a class="primary" href="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA4&amp;ie=ISO-8859-1&amp;source=gbs_selected_pages&amp;cad=4">Drawings</a>
</div>
<div class="selectedpagesthumbnail">
<a href="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA5&amp;ie=ISO-8859-1&amp;source=gbs_selected_pages&amp;cad=4"><img src="http://bks5.books.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA5&amp;img=1&amp;zoom=1&amp;sig=ACfU3U2EEAjVCUP8aEEab9KGIabFlbsQdw" alt="Drawings" title="Drawings" height="160" border="1"></a><br><a class="primary" href="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA5&amp;ie=ISO-8859-1&amp;source=gbs_selected_pages&amp;cad=4">Drawings</a>
</div>
<div class="selectedpagesthumbnail">
<a href="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA6&amp;ie=ISO-8859-1&amp;source=gbs_selected_pages&amp;cad=4"><img src="http://bks5.books.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA6&amp;img=1&amp;zoom=1&amp;sig=ACfU3U2YECCtu3he3pum1o7nlMRMIbdnKw" alt="Drawings" title="Drawings" height="160" border="1"></a><br><a class="primary" href="http://www.google.com/patents?id=UG8UAAAAEBAJ&amp;pg=PA6&amp;ie=ISO-8859-1&amp;source=gbs_selected_pages&amp;cad=4">Drawings</a>
</div>
<div style="clear:both;"></div>
</div></div>
</div>
</td>
</tr></table>
<script type="text/javascript">_OC_addFlags({LockSrc:"/books/javascript/lock_173f3eb08751494e5351928575aaa593.js", IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsGeoLayerEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:0, IsRatingsOnBookcardsEnabled:1, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_addMsgs();_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026ie=ISO-8859-1\u0026sig=ACfU3U197H040J0NZisdQzZenk55Sx4s1A\u0026id=UG8UAAAAEBAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026ie=ISO-8859-1\u0026sig=ACfU3U0_2BahZVLbWNxXBhqRkihFLO3tfA\u0026id=UG8UAAAAEBAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026ie=ISO-8859-1\u0026sig=ACfU3U0lm93F_zYC7UwmRD0GlNqyt8d08Q","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/6840954_Systems_and_methods_using_vasoco.pdf?id=UG8UAAAAEBAJ\u0026ie=ISO-8859-1\u0026output=pdf\u0026sig=ACfU3U29ppd0Fi_GRb3mBw9l5xYWxGBoew"},"sample_url":"http://www.google.com/patents/reader?id=UG8UAAAAEBAJ\u0026ie=ISO-8859-1\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em">
<div style="margin-bottom:8px">
<a href="http://www.google.com/"><nobr>Google&nbsp;Home</nobr></a> - <a href="//www.google.com/patents/sitemap/"><nobr>Sitemap</nobr></a> - <a href="http://www.google.com/googlebooks/uspto.html"><nobr>USPTO Bulk Downloads</nobr></a> - <a href="/intl/en/privacy/"><nobr>Privacy Policy</nobr></a> - <a href="/intl/en/policies/terms/"><nobr>Terms of Service</nobr></a> - <a href="//support.google.com/contact/bin/answer.py?hl=en&amp;answer=2539193"><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a>
</div>
<span>&copy;2012 Google</span>
</div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script>
</body>
</html>
